SQA Startup 5 — Questions and Answers
Question 1: Which scenario at study startup would trigger a formal protocol amendment rather than a minor administrative correction?
- Correcting a typographical error in the Study Director's name
- Changing the dose levels or duration of treatment (Correct answer)
- Fixing a formatting error in the table of contents
- Updating the document version number
Correct answer: Changing the dose levels or duration of treatment
Changes that affect the scientific conduct of the study, such as dose levels or duration, require a formal signed protocol amendment.
Question 2: In GLP, what is the required outcome if a test article mixture is prepared at study startup and homogeneity cannot be confirmed?
- Use the mixture and note the uncertainty in the report
- Do not use the mixture until homogeneity is analytically confirmed (Correct answer)
- Allow the sponsor to waive the homogeneity requirement
- Archive the mixture and prepare a new batch without testing
Correct answer: Do not use the mixture until homogeneity is analytically confirmed
Homogeneity of test article mixtures must be analytically verified before administration to ensure dose accuracy and data validity.
Question 3: A QA inspector discovers that the study protocol was signed after the first day of dosing. Which GLP principle has been violated?
- Data archiving requirements
- The requirement that the protocol be signed before study-specific procedures begin (Correct answer)
- Sponsor confidentiality rules
- Animal welfare regulations only
Correct answer: The requirement that the protocol be signed before study-specific procedures begin
GLP mandates that the Study Director sign the protocol before study-specific procedures commence; signing after dosing begins is a serious GLP violation.
Question 4: Which of the following best describes a 'startup meeting' in the context of a GLP study?
- A meeting held after the final report is delivered
- A pre-study meeting to align all personnel on protocol requirements, roles, and responsibilities (Correct answer)
- A regulatory inspection kickoff
- An annual review of archived studies
Correct answer: A pre-study meeting to align all personnel on protocol requirements, roles, and responsibilities
A startup meeting ensures all study personnel understand their roles, the protocol, and GLP expectations before work begins.
Question 5: Under GLP, if the sponsor requests that certain startup documentation remain confidential, what obligation does the test facility still have?
- Destroy the documents after sponsor review
- Maintain all required GLP records and make them available to regulatory inspectors (Correct answer)
- Transfer all documentation to the sponsor's site
- Exempt confidential documents from archiving
Correct answer: Maintain all required GLP records and make them available to regulatory inspectors
Regardless of confidentiality agreements, all GLP-required records must be retained and made available to regulatory authorities upon request.
Question 6: When verifying test article storage conditions at study startup, which parameter is LEAST likely to be included in GLP documentation?
- Storage temperature range
- Stability data supporting storage conditions
- The sponsor's marketing claims for the test article (Correct answer)
- Expiration or re-analysis date
Correct answer: The sponsor's marketing claims for the test article
Marketing claims are commercial information and are not GLP documentation requirements; temperature, stability, and expiry are all required.
Question 7: Which GLP record created at study startup provides a direct link between the study protocol and individual raw data entries throughout the study?
- The QA audit certificate
- The specimen label and unique sample identification system (Correct answer)
- The archiving checklist
- The sponsor's contract
Correct answer: The specimen label and unique sample identification system
A specimen labeling and unique sample identification system established at startup allows each data point to be traced back to the correct protocol and subject.
Which scenario at study startup would trigger a formal protocol amendment rather than a minor administrative correction?